New York, New York 10003


Purpose:

immobilization of yoked extra-ocular muscles in the anophthalmic orbit, in conjunction with platelet-rich-plasma, will improve integration of viable adipocytes injected into orbital fat


Study summary:

Immobilization of tissue (graft, graft bed) is a prerequisite for tissue integration. Since yoked extra-ocular muscles continue to be stimulated by movements of the seeing eye after fat injection into the anophthalmic orbit, the use of botulinum toxin(s) can be used to prevent movement of the orbital tissue bed(s) and improve anchoring of injected fat. Platelet rich plasma may also improve fat cell anchoring by the action of fibrin on the adhesion process. This innovation builds on the results of IRB protocols 10.27 and 12.01 as registered with Clinical Trials.gov


Criteria:

Inclusion Criteria: - anophthalmic enophthalmos in subjects within a 50 mile radius of New York City, grade 0-1 anesthesia risk, ages 21-75 Exclusion Criteria: - radiated orbits


NCT ID:

NCT02244671


Primary Contact:

Principal Investigator
Donald M Fox, MD
New York Eye and Ear Infirmary

Donald M Fox, MD
Phone: (212)772-1500
Email: dmfmdjr@yahoo.com


Backup Contact:

N/A


Location Contact:

New York, New York 10003
United States

Donald M Fox, MD
Phone: 212-772-1500
Email: dmfmdjr@yahoo.com

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.